Pharmaceutical Manufacturing and Formulation

The contract pertains to the manufacturing of PROMETHAZINE HYDROCHLORIDE TABLETS in full compliance with United States Pharmacopeia standards, encompassing the full lifecycle of production from active pharmaceutical ingredient sourcing to tablet compression and rigorous quality control procedures. All stages of the project must adhere to stringent regulatory requirements to ensure product safety, consistency, and efficacy, with a focus on meeting the exact specifications required for pharmaceutical use. The work is being executed under a subcontract agreement within the pharmaceutical manufacturing sector classified under NAICS code 325412. The contract is associated with the Defense Logistics Agency under the Department of Defense and was posted on August 9, 2026, with a procurement reference linked to SPE2DX25D8022 and delivery identifier SPE2D926F8075. Although specific geographic performance location details are not provided, the scope requires full-scale pharmaceutical production capabilities and quality assurance systems capable of supporting federal medical supply chain needs. The nature of the agreement reflects a critical supply responsibility for a mandated pharmaceutical agent intended for military or government healthcare applications.